|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.60 PLN | +7.79% |
|
+5.59% | -8.52% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +59.07% | 1 | ||||
| 58.6 | +26.51% | 10 | ||||||
| 24 | +6.34% | 7 | ||||||
| 43.67 | -0.1% | 6 | ||||||
| - | - | 48.3 | +26.57% | 1 | ||||
| 8.222 | +102.02% | 9 | ||||||
| 5.9 | -10.2% | 5 | ||||||
| - | 44,500 | +65.43% | 2 | |||||
| 8.333 | +79.21% | 3 | ||||||
| Average | 4,988.36 | +39.43% | 5 | ||||||
| Weighted average by Cap. | 2,461.33 | +27.39% | 6 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
